16.5.2024
15.5.2024
18
May
2024
22
24
Find more news and events
Suomeksi
In English
New sensitive and effective proteomics methods can be applied to identify potential novel drug targets in inflammatory conditions, leukemia and prostate cancer, according to the doctoral dissertation of Joanna Lempiäinen, MSc.
A new study conducted by researchers at the University of Eastern Finland found that the PLCG2-P522R genetic variant, which protects against Alzheimer’s disease, enhances several key functions of immune cells.